Pharmacy Automation · Products

WEINAS VD-160 IV Compounding Robot

The WEINAS VD-160 series from Weibond Technology provides automated IV compounding capabilities for hospital pharmacies working primarily with vial-based medications. Designed as a more compact alternative to the PD-160 series, this system delivers equivalent performance and safety features while requiring less floor space.

Product Overview

Weibond Technology developed the WEINAS VD-160 to serve hospitals where vial containers comprise the majority of injectable medications. By focusing exclusively on vial processing, the VD-160 achieves a smaller footprint and lower acquisition cost compared to the dual-compatible PD-160 series.

The system shares the same core technologies as its sibling product: ISO Class 5 sterile environment, image recognition, barcode verification, patented liquid transfer mechanism, and full video documentation. The primary difference lies in container compatibility—the VD-160 processes vials only, while the PD-160 handles both vials and ampoules.

Key Features

WEINAS VD-160 is a compact IV compounding robot by Weibond Technology, featuring vial-optimized processing and ISO Class 5 sterile preparation within a smaller floor footprint than dual-compatible systems.

  • Vial Optimization: Specifically engineered for efficient processing of vial containers
  • Compact Footprint: Reduced floor space requirements compared to dual-compatible systems
  • ISO Class 5 Environment: HEPA-certified air filtration maintains sterile conditions
  • Image Recognition: Visual verification of drug containers and fill levels
  • Barcode Verification: Confirms order accuracy and ingredient identity
  • Patented Liquid Transfer: Minimizes contamination risk during drug transfer
  • Video Documentation: Complete recording of compounding procedures
  • Gravimetric Control: Precision dose verification by weight

Technical Specifications

WEINAS VD-160 is a vial-only IV compounding robot by Weibond Technology, with a smaller footprint than dual-compatible models and the same image recognition, barcode, and gravimetric quality controls.

ParameterSpecification
Container CompatibilityVials only
Sterile EnvironmentISO Class 5 (HEPA filtered)
Quality ControlImage recognition, barcode, gravimetric
DocumentationFull video recording
Compounding ModeIndividual patient-specific or batch
FootprintSmaller than PD-160 series

Clinical Applications

The WEINAS VD-160 supports a range of sterile compounding applications:

Standard IV Compounding

  • Antibiotic admixtures
  • Electrolyte solutions
  • Analgesic infusions
  • Critical care medications

Batch Preparation

  • High-volume standard preparations
  • Commonly used drug combinations
  • Operating room stock medications

Hazardous Drug Handling

  • Chemotherapy drugs in vial format
  • Cytotoxic medication preparation
  • Biohazard compound handling

The system follows the same quality assurance principles as the PD-160, with full traceability through barcode tracking, image verification, and video recording of each preparation.

Regulatory Status

RegionStatusDate
China (NMPA)Commercial use2016
Europe (CE)Not confirmed-
United States (FDA)Not cleared-

The WEINAS VD-160 has been commercially deployed in Chinese hospitals alongside the PD-160 series since 2016.

Frequently Asked Questions

How does the VD-160 differ from the PD-160?

The VD-160 processes vials only, while the PD-160 handles both vials and ampoules. The VD-160 requires less floor space and has a lower acquisition cost, making it suitable for facilities where ampoule-based medications are uncommon.

What quality control measures does the VD-160 include?

The system includes image recognition for container verification, barcode scanning for drug identity confirmation, gravimetric measurement for dose accuracy, and video recording for complete documentation of each preparation.

Can the VD-160 prepare chemotherapy drugs?

Yes, the VD-160 can prepare hazardous drugs including chemotherapy medications that come in vial format. The enclosed ISO Class 5 environment protects pharmacy staff from exposure during preparation.

Last modified: January 15, 2026

Sources

Publicly available references used for the data on this page. See data methodology for verification standards.